Previous studies have shown that the heterozygous deletion of Sod2 in mice can promote mitochondrial oxidative stress (16), whereas genetic polymorphisms in SOD2 in humans that decrease SOD2 mitochondria targeting and activity may be associated with NASH and the severity of fibrosis (22, 68). This evidence concerns the gene SOD2 and metabolic dysfunction-associated steatohepatitis.